🌐 EN ▾
  • EN - English
  • FR - French
  • DE - German
  • JP - Japanese
  • KR - Korean

Liposomal Strength
for Every Step

Boswellia serrata - Nature’s Solution for Mobility

Boswellia serrata (Salai guggul), has been used for centuries in Ayurveda and Unani medicine. Its active compounds, boswellic acids, are known for their anti-inflammatory, analgesic, and joint-supporting properties.

Barriers to Bioavailability

1

Poor Water
Solubility

Boswellic acids are hydrophobic and dissolve poorly in water

2

Low Intestinal
Absorption

Limited absorption reduces systemic availability

3

Rapid
Metabolism

Quick breakdown in the liver further decreases bioavailability

The LIPOWELL ™ Advantage

LIPOWELL™ is powered by DFS Technology™ (Dietary Fiber Stabilized), a patent filed liposomal delivery system that encapsulates boswellic acids. This enhances solubility, protects the active compounds, and improves absorption for optimal joint health, inflammation management and mobility support.

Grade/Specification
Available Form
Liposomal Boswellia – 10%
Powder

Core Benefits of LIPOWELL™

Heart

Supports Healthy Inflammation
Response

Shield

Promote Joint Health & Mobility

Brain

Support Respiratory Wellness

Face

Enhance Immune Function

Backed by Science, Proven in Research

Cellular Uptake Study (Caco-2 model): Liposomal Boswellia demonstrated 2.1× higher permeability than non-liposomal Boswellia, optimizing absorption and efficacy.

Analytical Validation: LIPOWELL™ features perfectly shaped particles confirmed by TEM analysis, with Zeta and PDI reports indicating a uniform and stable formulation.

Why LIPOWELL™ is Superior?

Feature
LIPOWELL™ Liposomal Boswellia
Conventional Boswellia
Absorption Technology
DFS Technology™ – advanced liposomal delivery
Poor water solubility limits absorption
Cellular Permeability
2.1× higher absorption and tissue penetration (proven in studies)
Low permeability due to hydrophobic nature
Stability & Efficacy
Protected from digestive degradation, ensuring sustained activity
Rapidly metabolized, reducing therapeutic efficacy
Analytical Validation
TEM, Zeta, and PDI validated for liposomal integrit
No advanced validation of formulation stability
Tolerance
Gentle, efficient delivery with improved tolerability
May cause mild gastrointestinal discomfort

Backed by External Peer-Reviewed Research

SPRINGER | Inflammopharmacology

STUDY YEAR | 2025 | Somayyeh Shateri et al.

Boswellic acids as an adjunct therapy in Parkinson's disease (PD): a double-blind clinical trial investigating its effects on motor symptoms and inflammatory markers. Boswellic acids may help...

Read More

TAYLOR & FRANCIS | Journal of Dietary Supplements

STUDY YEAR | 2025 | Sepideh Barzin Tond et al.

Boswellic Acids Reduce Systemic Inflammation in Patients with Moderate COVID-19 Through Modulation of NF-ÎşB Pathway. Boswellic acids...

Read More

SPRINGER | Inflammopharmacology

STUDY YEAR | 2021 | Adel A. Gomaa et al.

Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly- Boswellia serrata shows potential...

Read More

SPRINGER | Anti-Inflammatory Nutraceuticals and Chronic Diseases

STUDY YEAR | 2016 | H. P. T. Ammon

Boswellic Acids and Their Role in Chronic Inflammatory Diseases. Boswellic acids reduce inflammation and improve...

Read More

ELSEVIER | Phytomedicine

STUDY YEAR | 2003 | N. Kimmatkar et al.

Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee – a randomized double-blind placebo-controlled trial. Boswellia serrata extract significantly reduced knee...

Read More

Š 2026 LipsoBioŽ All Rights Reserved.

Disclaimer -

top